Stryker (SYK) Net Margin (2009 - 2026)
Stryker (SYK) posted quarterly Net Margin of 19.37% for Q2 2026, up 469.0% year-over-year from 3.4% in Q2 2025, and up 56.48% on a QoQ basis from 12.38% in Q1 2026.
Stryker (SYK) Net Margin (2009 - 2026) Analysis & Trends
Stryker has reported Net Margin for 18 years, with the latest figure at 19.37% in Q2 2026.
- Net Margin for Q2 2026 came in at 19.37%, up 469.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 14.43% (up 218.0% YoY), and the FY2025 annual result was 12.92%, down 32.0% from the prior year.
- Net Margin grew to 19.37% in Q2 2026, from 12.38% in the prior quarter.
- Over five years, Net Margin peaked at 19.66% in Q4 2023 and troughed at 7.56% in Q1 2022.
- A 5-year average of 13.87% and a median of 14.39% in 2022 frame the typical range for Net Margin.
- The widest annual swing landed in 2023, when Net Margin surged 883 bps; it then tumbled 1117 bps in 2024.
- A 5-year view of Net Margin shows it stood at 10.82% in 2022, then surged by 82 bps to 19.66% in 2023, then plunged by 57 bps to 8.48% in 2024, then surged by 40 bps to 11.84% in 2025, then soared by 64 bps to 19.37% in 2026.
- Per Business Quant data, the three most recent Net Margin figures were 19.37% in Q2 2026, 12.38% in Q1 2026, and 11.84% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 7.37% |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 19.37% |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 16.67% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 13.87% |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 19.04% |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 10.84% |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | 6.47% |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 13.47% |
| 10 | Zimmer Biomet Holdings | 19.37 Bn | 18.96 Bn | 1.54 Bn | 9.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.37% |
| Mar 31, 2026 | 12.38% |
| Dec 31, 2025 | 11.84% |
| Sep 30, 2025 | 14.18% |
| Jun 30, 2025 | 14.68% |
| Mar 31, 2025 | 11.15% |
| Dec 31, 2024 | 8.48% |
| Sep 30, 2024 | 15.18% |
| Jun 30, 2024 | 15.22% |
| Mar 31, 2024 | 15.03% |
| Dec 31, 2023 | 19.66% |
| Sep 30, 2023 | 14.10% |
| Jun 30, 2023 | 14.77% |
| Mar 31, 2023 | 12.39% |
| Dec 31, 2022 | 10.82% |
| Sep 30, 2022 | 18.22% |
| Jun 30, 2022 | 14.60% |
| Mar 31, 2022 | 7.56% |
| Dec 31, 2021 | 14.08% |
| Sep 30, 2021 | 10.53% |